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Infection with an obligate intracellular bacterium, the Chlamydia trachomatis lymphogranuloma venereum
(LGV/L2) strain or the guinea pig inclusion conjunctivitis serovar of Chlamydia psittaci, leads to apoptosis of
host cells. The apoptosis is not affected by a broad-spectrum caspase inhibitor, and caspase-3 is not activated
in infected cells, suggesting that apoptosis mediated by these two strains of Chlamydia is independent of known
caspases. Overexpression of the proapoptotic Bcl-2 family member, Bax, was previously shown to induce
caspase-independent apoptosis, and we find that Bax is activated and translocates from the cytosol to the
mitochondria in C. psittaci-infected cells. C. psittaci-induced apoptosis is inhibited in host cells overexpressing
Bax inhibitor-1 and is inhibited through overexpression of Bcl-2, which blocks both caspase-dependent and
-independent apoptosis. As Bax and mitochondria are ideally located to sense stress-related metabolic changes
emanating from the interior of an infected cell, it is likely that Bax-dependent apoptosis may also be observed
in cells infected with other intracellular pathogens.
Cell death occurs through different mechanisms that can be
distinguished morphologically and biochemically. The most
common forms of cell death are necrosis and apoptosis (24, 57,
58). The hallmarks of apoptosis are condensation of the nu-
clear chromatin and cytoplasm, activation of cysteine proteases
(caspases) and endonucleases, loss of plasma membrane phos-
phatidylserine asymmetry, cleavage of the DNA into oligonu-
cleosomal fragments, and segmentation of the dying cell into
membrane-bound apoptotic bodies. During apoptosis in vivo,
the apoptotic bodies are phagocytosed by neighboring cells in
such a way that the contents are degraded intracellularly, usu-
ally without provoking inflammation. A number of viral, bac-
terial, and parasitic infections affect viability of the host cell,
either inhibiting or promoting host cell apoptosis (4, 47, 54).
Some microbes may protect infected cells against apoptosis
induced by effector cells and soluble mediators of the immune
system, while other microbes may trigger apoptosis of immune
effector cells (21, 54).
In the nematode Caenorhabditis elegans, apoptosis is regu-
lated by genes named for their cell death-defective (CED)
quality (16). Two of the genes, ced-3 and ced-4, are necessary
for execution of apoptosis. The mammalian homolog of
CED-3 is a family of caspases, which contains at least 14
members (35, 48). In mammalian cells, caspases are present as
inactive procaspases and are proteolytically processed into
active caspases. Specific caspase inhibitors, consisting of small
tri- or tetrapeptides, have been developed that inhibit most
types of apoptosis studied to date (22).
Caspases can be activated through engagement of cell sur-
face receptors such as the tumor necrosis factor alpha receptor
and Fas (39) or release of cytochrome c from mitochondria
(31). Dysfunction of mitochondria can lead to redistribution of
cytochrome c to the cytosol, which can activate caspase-9 in the
presence of dATP and the CED-4 homolog, the procaspase-
processing factor Apaf-1 (33). Caspase-9 in turn activates the
effector caspase-3 that is responsible for many of the morpho-
logical and biochemical features of apoptosis (35, 48).
Mitochondria can be induced to release cytochrome c
through a myriad of weak stress signals emanating from the
interior of the cell or following activation of caspases stimu-
lated by ligation of surface receptors (26). The integrity of the
mitochondrial outer membrane and cytochrome release are
regulated by the Bcl-2 family of proteins, which consist of
antiapoptotic factors such as Bcl-2 and Bcl-xL, and proapop-
totic proteins such as Bax and Bak (1). These proteins can
heterodimerize with each other and interact with mitochon-
dria, where they play a key role in deciding whether a cell will
live or die (26, 27). Thus, Bcl-2 proteins prevent apoptosis by
preventing the release of mitochondrial interspace proteins,
including cytochrome c and the apoptosis inducing factor,
while Bax stimulates release of cytochrome c from mitochon-
dria, resulting in apoptosis (46, 50).
Recent studies demonstrate that some types of cell death
can take place in the absence of caspase activation. In a grow-
ing number of cell death models, specific caspase inhibitors
were unable to inhibit apoptosis induced by proapoptotic stim-
uli (14, 36, 60) and caspase activation was not sufficient for
initiating apoptosis (8). In addition, overexpression of Bax or
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Bak induces cell death without the involvement of caspases
(44, 60), suggesting that factors other than caspases can also
mediate apoptosis. Some of these factors may reside normally
in mitochondria. Apoptosis inducing factor, for example, pro-
motes mitochondrial swelling, chromatin condensation, and
cytochrome c release in the absence of caspase activation (52).
Most apoptotic pathways characterized to date have been
triggered via surface receptors or induced with unphysiological
ligands such as staurosporine, and most have relied on caspase
activation for cell death to occur. Pathways initiated within the
cell under physiological conditions have attracted less atten-
tion, and there are few models for caspase-independent pathways.
We have recently reported that infection in vitro by an ob-
ligate intracellular bacterium, the guinea pig inclusion conjunc-
tivitis (GPIC) strain of Chlamydia psittaci or the mouse pneu-
monitis (MoPn) strain of Chlamydia trachomatis, results in
morphological and biochemical changes in infected epithelial
cells and macrophages that are characteristic of apoptosis, such
as DNA fragmentation, condensation of nuclei, and positive
staining with the terminal deoxynucleotidyltransferase-medi-
ated dUTP-biotin nick end labeling technique, and that infec-
tion by the MoPn strain of C. trachomatis leads to shedding of
apoptotic cells into the genital tract of infected mice in vivo
(42, 45). In addition, apoptosis has been observed to occur in
the genital tract of guinea pigs following infection with C. psittaci
(12).
Chlamydia species are causative agents of a large spectrum
of diseases in humans and animals (7, 9, 49). There are four
known species of Chlamydia: C. trachomatis, C. psittaci, C.
pneumoniae, and C. pecorum. The C. trachomatis serovars are
responsible for infections of ocular tissue and sexually trans-
mitted diseases in humans. C. psittaci elicits different symp-
toms, depending on its host. It causes intestinal infections in
birds and abortion in pregnant ewes, but in humans it mani-
fests itself as pneumonia. C pneumoniae is responsible for
about a tenth of all pneumonias in humans and has recently
been linked to atherosclerosis. C. pecorum is associated with
infectious pneumonitis in domestic animals. However, in spite
of the clinical and economic importance of Chlamydia infec-
tions, the biology of the infections is not well characterized (6,
51). The bacteria exist in two developmental forms: the infec-
tious extracellular elementary bodies (EB) attach to the host
cell and are internalized into a vacuole that avoids fusion with
host cell lysosomes. Within 8 to 10 h, the EB differentiate into
multiplicative intracellular reticulate bodies, which proliferate
within the same membrane-bound vacuole. After several divi-
sions, the reticulate bodies differentiate back into EB, and
after 2 to 3 days, depending on the Chlamydia strain, the EB
are released from the infected cell through unknown mecha-
nisms and begin a new cycle of infection (38). The apoptosis
observed at the end of the infection cycle could thus be in-
volved in release of EB from the host cell and could partially
contribute to the inflammatory response of the host, since
macrophages undergoing apoptosis secrete inflammatory cyto-
kines (28).
As C. psittaci-induced apoptosis was not sensitive to a spe-
cific inhibitor of caspase-3, we had proposed that the apoptosis
may be independent of caspases (42). We now confirm the
caspase independence by demonstrating that a broad-spectrum
caspase inhibitor has no effect on the apoptosis during infec-
tion by C. psittaci or the C. trachomatis lymphogranuloma
venereum (LGV/L2) strain and that caspase-3 is not activated
during the infection. In order to characterize the molecular
basis for the apoptosis, we studied the activation and distribu-
tion of Bax during Chlamydia infection and the influence of
Bax inhibitor-1 (BI-1) and Bcl-2 on Chlamydia-induced apo-
ptosis.
MATERIALS AND METHODS
Materials, cells, and bacteria. Cytochalasin D, leupeptin, pepstatin A, TPEN
[N,N,N,N-tetrakis (2-pyridylmethyl)ethylenediamine], and staurosporine were
from Sigma (St. Louis, Mo.). The caspase inhibitor z-VAD-fmk [z-Val-Ala-Asp-
(OMe)-fmk] was from Enzyme Systems Products (Livermore, Calif.). The hu-
man cervical adenocarcinoma cell line, HeLa 229; the human monocytic cell line,
U937; and the C. trachomatis strain of the lymphogranuloma venereum (LGV/
L2) strain were from the American Type Culture Collection (Manassas, Va.).
The GPIC serovar of C. psittaci was from Roger Rank (University of Arkansas,
Little Rock). Bacteria were prepared and cells were infected as previously de-
scribed (42).
Transfections and clones. The pcDNA3-BI-1-HA (61) and the pcDNA3-sbcl-2
plasmid (2), the stable U937 cell lines U937 overexpressing Bcl-2 (U937 CMV-s
bcl-2), the control cell line U937pcDNA3 (2), and the stable HeLa cell lines
overexpressing Bcl-2 (17) were previously described. DNA transfection of HeLa
cell lines was performed using the FuGENE 6 Transfection Reagent kit (Boehr-
inger Mannheim GmbH, Mannheim, Germany). Briefly, 2  105 HeLa cells/well
were transfected in six-well plates (Costar) with 2 g of plasmid DNA and 100
l of FuGENE 6 Reagent diluted with serum-free Dulbecco modified Eagle
medium. After incubation at room temperature for 15 min, the mixture was
distributed in 35-mm-diameter culture dishes. The cells were infected 17 h after
transfection. The expression level of pcDNA3-BI-1-HA and pcDNA3-Bcl-2 in
HeLa cells and of Bcl-2 in the stable U937 transfectants was assessed by immu-
nofluorescence microscopy and cytofluorimetry with rabbit polyclonal antibody
(C21) against human Bcl-2 (Santa Cruz Biotechnology, Santa Cruz, Calif.) and
fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobulin
G (heavy and light chain) [IgG (H  L)] (Jackson Immuno Research Labora-
tories; West Grove, Pa.) or with antihemagglutinin (anti-HA) antibody (12CA5;
kindly provided by Alain Israel, Institut Pasteur) and Fluorolink Cy3-labeled
goat anti-mouse IgG (H  L) (Amersham Pharmacia Biotech, Little Chalfont,
United Kingdom).
Analysis of apoptosis. Quantitative measurement of apoptosis was performed
by cytofluorimetry of detergent-permeabilized propidium iodide-stained cells as
described (40, 42). Both adherent cells and cells in suspension were collected for
analysis. For cells transfected with the BI-1 or Bcl-2 constructs, apoptosis was
quantified by immunofluorescence microscopy. Condensed nuclei were counted
in Hoechst-stained cells that overexpressed Bcl-2, as observed with the anti-Bcl-2
antibody, or BI-1–HA, as revealed with the anti-HA antibody.
Caspase-3 activity assay. Whole-cell extracts were obtained by dissolving
HeLa cells in lysis buffer containing 50 mM piperazine-N,N-bis(2-ethanesulfonic
acid) (PIPES)-NaOH (pH 7.5), 50 mM KCl, 5 mM EGTA, 2 mM MgCl2, 1 mM
dithiothreitol (DTT), 20 M cytochalasin D, 1% 3-[(3-cholamidopropyl)-di-
methylammonio]-1-propanesulfonate (CHAPS), leupeptin (1 g/ml), pepstatin
A (1 g/ml), and 1 mM phenylmethylsulfonyl fluoride (PMSF). Samples were
vortexed and sonicated in a cold-water sonicator. After centrifugation, the pellet
was discarded and supernatants were stored at 20°C until ready for use. Mea-
surement of protein concentration was performed with the Bio-Rad Protein
Assay (Bio-Rad Laboratories GmbH, Munich, Germany).
Lysates (25 g of cytosolic protein) were diluted in 50 l of buffer A (25 mM
HEPES [pH 7.5], 5 mM MgCl2, 5 mM EDTA, 1 mM EGTA, 1 mM PMSF, 1 mM
DTT, pepstatin A [10 g/ml], and leupeptin [10 g/ml]) to which was added 225
l of buffer B (25 mM HEPES [pH 7.5], 0.1% CHAPS, 10 mM DTT, 1 mM
PMSF) containing 100 M DEVD-AFC (Alexis, San Diego, Calif.). Samples
were incubated for 4 h at 37°C. Cleavage of the substrate resulted in enhanced
fluorescence, which was quantified in a Perkin-Elmer LS50 luminescence spec-
trometer (excitation wavelength, 360 nm; emission wavelength, 475 nm).
Immunofluorescence microscopy. For immunocytochemistry analysis, cells
were seeded onto glass coverslips and then infected or kept as uninfected con-
trols. The cells were then washed in phosphate-buffered saline (PBS) and fixed
with 4% paraformaldehyde in PBS for 15 min. After washing, the cells were
incubated for 1 h with the N-20 anti-Bax polyclonal antibody (Santa Cruz Bio-
technology) at a 1:100 dilution in permeabilization buffer (bovine serum albumin
[1 mg/ml] and 0.05% saponin in PBS), washed twice in PBS-bovine serum
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albumin buffer, and revealed with a FITC-conjugated goat anti-rabbit IgG
(HL) (Jackson Immuno Research Laboratories). A monoclonal antibody
against mitochondrial hsp70 (Affinity Bioregents, Golden, Colo.) was used at a
dilution of 1:100, followed by Alexa Fluor 546 goat anti-mouse second antibody
(Molecular Probes, Eugene, Oreg.) at a 1:100 dilution. Hoechst dye (5 g/ml)
was added to the cells in order to detect apoptotic nuclei. Fluorescently labeled
samples were examined under a fluorescent microscope (Axiophot; Zeiss, Jena,
Germany) attached to a cooled charge-coupled device camera (Photometrics,
Tucson, Ariz.), using X63 Neofluar lenses, or by confocal microscopy, as de-
scribed (41).
RESULTS
Caspase independence of Chlamydia-induced cell death. We
have previously reported that C. psittaci infection leads to
apoptosis in epithelial cells and in monocytes in vitro (42) and
that the MoPn strain of C. trachomatis causes apoptosis both in
vitro and in vivo in infected mice (45). Based on the ability of
a caspase-3 inhibitor to block Fas-induced apoptosis but not
Chlamydia-induced apoptosis, we had proposed that the apo-
ptosis observed during infection may be independent of
caspase-3 (42).
To determine whether other known caspases may be in-
volved in apoptosis during infection, we studied the effects of
the broad-spectrum caspase inhibitor, z-VAD-fmk, in two dif-
ferent human cell lines, HeLa epithelial cells and U937 mono-
cytic cells. We also evaluated, as positive controls, the effect of
FIG. 1. Caspase-independent cell death during infection of epithelial cells or monocytes with the GPIC strain of C. psittaci or the LGV/L2 strain
of C. trachomatis. HeLa (A) and U937 (B) were infected with C. psittaci, at an MOI of 0.7 and 1.0, respectively, or with C. trachomatis at an MOI
of 0.3, for 48 h in the presence or absence of 100 M z-VAD-fmk. As positive controls for caspase-dependent cell death, HeLa cells were incubated
with 15 M TPEN for 17 h, and U937 cells were incubated with anti-Fas antibody (0.5 g/ml) for 16 h. Apoptosis was measured by cytofluorimetry
as described in Materials and Methods. The values represent the means and standard deviations (error bars) of three separate experiments. (C)
Caspase-3 activity was measured in lysates from HeLa cells infected with C. psittaci for 48 h or treated with TPEN for 17 h, using the fluorescent
substrate for caspase-3, DEVD-AFC, as described in Materials and Methods. The same level of apoptosis was measured in TPEN-treated or
Chlamydia-infected cells under these conditions. The extent of DEVD-AFC cleavage in TPEN-treated cells was defined as 100, and the other
values were normalized with respect to this positive control. The values represent the means and standard deviations (error bars) of three samples
treated with TPEN or infected with Chlamydia on separate days.
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this inhibitor on apoptosis due to incubation with the zinc
chelator TPEN (30) or staurosporine (62) in HeLa cells, or
with anti-Fas antibodies in U937 cells. After a 1-h incubation
with 100 M z-VAD-fmk, the cells were either infected for
48 h with a multiplicity of infection (MOI) of 0.7 (HeLa) and
1.0 (U937), treated for 17 h with 15 M TPEN or for 24 h with
1 M staurosporine (HeLa), or incubated for 16 h with anti-
Fas antibody (0.5 g/ml) in the presence of cycloheximide
(U937) (2 g/ml). As nuclei of apoptotic cells undergoing
DNA fragmentation contain subdiploid amounts of DNA, ap-
optosis was quantified by cell cycle analysis with propidium
iodide-stained cells (40). The inhibitor protected cells from
apoptosis due to incubation of HeLa cells with TPEN (Fig. 1A)
or staurosporine (not shown) or incubation of U937 cells with
anti-Fas antibodies (Fig. 1B), suggesting that the caspase in-
hibitor was used at a sufficiently high concentration to decrease
caspase-dependent apoptosis in HeLa or U937 cells. In con-
trast, z-VAD-fmk had no effect during infection with either C.
psittaci or the LGV/L2 strain of C. trachomatis (Fig. 1A and B).
Given the apparent caspase independence of apoptosis dur-
ing Chlamydia infection, we examined the activation of
caspase-3. A common step during late stages of many apopto-
tic processes is activation of caspase-3 (56), which we assayed
by measuring the ability of lysates from infected or TPEN-
treated HeLa cells to cleave the fluorogenic substrate of
caspase-3, DEVD-AFC. In HeLa cells that had been treated
with TPEN, there was a high level of caspase-3 activity, which
was completely inhibited by z-VAD-fmk (Fig. 1C). However,
under conditions in which the same percentage of cells is
apoptotic, there was little if any caspase-3 activation after 48 h
of infection with C. psittaci (Fig. 1C). These results are consis-
tent with the observation that z-VAD-fmk does not have a
significant effect on apoptosis during infection (Fig. 1A and B)
and reinforce the interpretation that Chlamydia-induced apo-
ptosis is independent of known caspases.
Bax activation during Chlamydia infection. The proapop-
totic protein Bax, a member of the Bcl-2 family, is activated in
numerous cell lines in response to a variety of apoptotic stimuli
(60) and translocates from the cytosol to mitochondria upon
induction of apoptosis (55). In addition, overexpression of Bax
induces apoptosis through mechanisms that are independent
of caspases (60).
To determine whether Bax may play a role in C. psittaci-
induced apoptosis, Bax activation was measured by cytofluo-
rimetry. The anti-Bax antibody used, N-20, is specific for the
Bax N terminus, which becomes exposed during Bax activation
(15, 25, 29). Staining with this antibody increases after a 48-h
infection with C. psittaci, compared to uninfected cells (Fig.
2A). To determine whether enhanced antibody binding to in-
fected cells may be due to new synthesis of Bax, the cells were
infected in the presence of a protein synthesis inhibitor. Cy-
cloheximide did not decrease the level of Bax expression shown
in Fig. 2A (data not shown), suggesting that preexisting Bax is
activated during infection.
Finally, we investigated the subcellular distribution of Bax in
HeLa cells infected with C. psittaci for 48 h. Normal nuclei
were observed in uninfected cells (Fig. 2B), while segmenting
nuclei were found in many cells containing Chlamydia inclu-
sions (Fig. 2C). In uninfected cells from the same experiment,
diffuse cytoplasmic staining was observed with the anti-Bax
antibody (Fig. 2F), which had a distribution different from that
of mitochondria (Fig. 2D). In cells infected with C. psittaci
(Fig. 2G), the staining of Bax became punctate and more
intense, especially in cells displaying condensed nuclei, and
colocalized with mitochondria (Fig. 2E).
Effect of BI-1 or Bcl-2 overexpression on Chlamydia-induced
apoptosis. Since BI-1 interacts with Bcl-2 family members and
inhibits apoptosis mediated by Bax but not by Fas (61), we
infected HeLa cells that expressed transiently the BI-1 protein.
As shown in Fig. 3A, BI-1 overexpression resulted in a 90%
inhibition of apoptosis during infection, suggesting that Chla-
mydia-induced apoptosis may require the activity of Bax.
Bax is an antagonist of the antiapoptotic protein Bcl-2 (1),
and overexpression of Bcl-2 can inhibit caspase-independent
apoptosis (3, 43). We therefore investigated whether Bcl-2
overexpression has any effect on C. psittaci-induced apoptosis.
Compared to untransfected cells, transient overexpression of
Bcl-2 led to 80% specific inhibition of apoptosis due to infec-
tion with C. psittaci, and there was also inhibition in epithelial
or monocytic clones overexpressing Bcl-2 permanently (Fig.
3B). Thus, Bcl-2 blocks the Bax-dependent, caspase-indepen-
dent apoptosis due to Chlamydia infection.
DISCUSSION
We have previously observed apoptosis during infection of
epithelial cells and macrophages with C. psittaci GPIC or C.
trachomatis MoPn in vitro (42, 45) and in the genital tract of
mice infected with C. trachomatis MoPn in vivo (45). To eval-
uate the relationship between Chlamydia infection and cell
death, we investigate here the involvement of caspases and the
role of the Bcl-2 family of proteins during Chlamydia infection.
We have previously shown that caspase-1 is activated during
infection and participates in processing of interleukin-1 in
monocytes, although caspase-1 is not involved in C. psittaci-
induced apoptosis. An inhibitor of caspase-3 also had no effect
on the level of apoptosis, suggesting that this caspase is not
required for this pathway of apoptosis (42). In the present
study, we show that the broad-spectrum caspase inhibitor, z-
VAD-fmk, has no effect on apoptosis during C. psittaci GPIC
or C. trachomatis LGV/L2 infection, even though it inhibits cell
death pathways that rely on caspases. Furthermore, there was
essentially no activation of caspase-3 during Chlamydia infec-
tion, compared to the levels observed in the same cells treated
with the caspase-dependent apoptosis trigger, TPEN, whose
apoptosis could be inhibited by z-VAD-fmk. These results sug-
gest that caspases do not participate in the apoptosis observed
during infection by C. psittaci GPIC or C. trachomatis LGV/L2
and that caspases are not activated during infection or, as
previously proposed (18), are inhibited by the infection.
We next evaluated the role that two Bcl-2 family proteins
(the proapoptotic protein, Bax, and the antiapoptotic protein,
Bcl-2) may play during Chlamydia-induced apoptosis. We ob-
served that the Bax protein redistributes to mitochondria in
cells undergoing apoptosis and that the intensity of staining
increases. Enhanced staining was confirmed by cytofluorimetry
and was not affected by the protein synthesis inhibitor cyclo-
heximide. These results are thus consistent with the observa-
tion that cycloheximide has no effect on apoptosis during C.
psittaci infection (42) and are reminiscent of reports that Bax
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or Bak overexpression results in a cell death that does not
depend on caspases (44, 60). Apoptosis during C. psittaci in-
fection could be blocked by overexpression of the Bax inhibi-
tor, BI-1, suggesting that Bax activation is also required for this
cell death.
Many apoptotic stimuli cause relocalization of cytochrome c
from the mitochondria to the cytosol, resulting in activation of
the effector caspases, including caspase-3, in the presence of
Apaf-1, pro-caspase-9 and ATP (34, 64). Bcl-2 normally inter-
feres with this caspase activation (11), but it can also partially
inhibit apoptosis at a postmitochondrial step, in cells that have
been injected with cytochrome c (63). More importantly, Bcl-2
can suppress both caspase-dependent and caspase-indepen-
dent pathways of apoptosis (11, 37, 43). We therefore studied
the effect of Bcl-2 overexpression on apoptosis of monocytic or
epithelial cells infected with C. psittaci. With either host cell
type, apoptosis due to infection was inhibited significantly by
Bcl-2.
Our results on the caspase independence of apoptosis during
Chlamydia infection are consistent with a report that C. tra-
chomatis infection inhibits release of cytochrome c from mito-
chondria and inhibits caspase activation when host cells are
treated with staurosporine or anti-Fas antibodies (13, 18). It is
thus likely that, at least for some strains, Chlamydia infection
may both protect infected cells against apoptosis due to exter-
nal ligands and induce apoptosis towards the end of the infec-
tion cycle (21). C. pneumoniae has also been reported to pro-
tect infected peripheral blood mononuclear cells against
apoptosis, but through a different mechanism, involving secre-
tion of interleukin-10 from infected cells (23). Apoptosis has
now been described for infections with C. psittaci serovar
GPIC, C. trachomatis MoPn strain, and C. trachomatis LGV/L2
strain (references 42 and 45 and this work), but an uncharac-
terized host cell death due to infection with low multiplicities
of Chlamydia has also been previously reported for fibroblasts
(L cells) and peritoneal macrophages infected with the menin-
gopneumonitis strain, the 6BC strain, and the LW-613 strains
of C. psittaci (10, 19, 53, 59), with a time course similar to what
has been reported for apoptosis (onset of cell death beginning
20 to 36 h after the beginning of infection). In a plaque assay
for infection with over 100 isolates of Chlamydia, all isolates
of avian, mammalian, and human origin were cytotoxic for L
cells, with the exception of slow-growing trachoma-inclusion-
conjunctivitis agents (IC-Cal-3 and Apache 2) (5). While it is
tempting to speculate that some of these strains cause host cell
death through apoptosis, it is also possible that only some
strains induce apoptosis. A careful study of host cell death and
survival of cells infected with different strains should allow us
to determine if the pro- and antiapoptotic activities are a gen-
eral characteristic of Chlamydia infections.
Both inhibition and induction of apoptosis have been previ-
ously reported for other intracellular pathogens, including her-
pes simplex virus 1 (20). In the case of cells infected with a
herpes simplex virus 1 mutant, apoptosis could take place in
the presence of caspase inhibitors, similarly to apoptosis due to
Chlamydia infection. Likewise, infection by the human adeno-
virus induces apoptosis through a mechanism that involves
activation of caspases but is not inhibitable by the broad-spec-
trum caspase inhibitor z-VAD-fmk. However, adenovirus-me-
diated apoptosis is inhibited by overexpression of Bcl-2 or
FIG. 2. Bax activation during infection with Chlamydia. (A) Bax
activation was measured in HeLa cells by cytofluorimetry with the
anti-Bax antibody (N-20). The dotted line represents the spectrum in
the absence of N-20 antibody, the solid line corresponds to Bax stain-
ing in uninfected cells incubated with N-20 and FITC-conjugated sec-
ond antibody, and filled spectrum shows Bax staining in cells infected
for 48 h and incubated with N-20 and second antibody. Bax activation
and intracellular distribution were also evaluated by confocal micros-
copy. Nuclei stained with Hoechst of uninfected HeLa cells (B) or cells
infected with C. psittaci for 48 h (C), showing fragmenting nuclei in in-
fected cells, are shown. The arrowhead indicates a Chlamydia inclusion.
Subcellular localization of Bax (F) and mitochondria (D) in uninfected
cells is shown. Subcellular localization of Bax (G) and mitochondria
(E) in cells undergoing apoptosis in infected sample is also shown.
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Bcl-xL (32). Inhibition of apoptosis due to external ligands may
therefore protect infected cells against proapoptotic effectors
of the immune system. Conversely, Bax activation during later
stages of infection may be a general phenomenon occurring
during other types of intracellular infections and could reflect
a stress response in the infected cell (6).
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